A
Avalo Therapeutics, Inc. (AVTX)
NCM – Real Time Price. Currency in USD
13.89
-0.06 (-0.43%)
At close: Mar 27, 2026, 4:00 PM EDT
13.89
0.00 (0.00%)
After-hours: Mar 27, 2026, 5:20 PM EDT
Get all premium features to the best stock analysis tool
NCM – Real Time Price. Currency in USD
13.89
-0.06 (-0.43%)
At close: Mar 27, 2026, 4:00 PM EDT
13.89
0.00 (0.00%)
After-hours: Mar 27, 2026, 5:20 PM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 14.28 | 6.05 | 10 | |
| Quick ratio | 14.28 | 5.63 | 10 | |
| Debt to Equity | 0.03 | 0.30 | 9.0 | |
| Debt to Assets | 0.02 | 1.04 | 9.0 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 7.8 | |||
| METRIC | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 5M | 18M | 2M | 441K | 192K |
| Gross Profit | 2M | 15M | 640K | 638K | -223K |
| Operating Income | -82M | -37M | -23M | -41M | -66M |
| Net Income | -84M | -42M | -32M | -35M | -100M |
| EBITDA | -80M | -37M | -23M | -41M | -66M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | -100 | 36.59 | 5.5 |
| Next quarter | N/A | -20.09 | 1.0 |
| Current year | -100 | 67.9 | 5.5 |
| Next year | N/A | 16.85 | 5.0 |
| Weighted average score | 4.3 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | -47.47 | -14.05 | -43.67 | 3.3 |
| Y/Y | -99.99 | -232.93 | 22.61 | -41.96 | 3.3 |
| 3y average | 22.67 | 21.18 | 75.49 | -3.9 | 7.8 |
| 5y average | 9.57 | -26.68 | 4.07 | -39.18 | 3.0 |
| Weighted average score | 4.4 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Company's cash reserves $27.1M significantly exceed its total debt $2.6M, ensuring strong financial flexibility
Total current assets $113.8M exceed Total current liabilities $8.0M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$16.4M limits the company's ability to reinvest or pay down debt